Last update 02 Feb 2026
Beijing Tumor Hospital

Beijing Tumor Hospital

Hospital|1976|Beijing Shi, China|
www.bjcancer.org

Overview

Tags

Neoplasms
Urogenital Diseases
Digestive System Disorders
Diagnostic radiopharmaceuticals
Peptide Conjugate Radionuclide
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms10
Top 5 Drug TypeCount
Diagnostic radiopharmaceuticals7
Peptide Conjugate Radionuclide3
Small molecule drug1
Small molecule-drug conjugates1
Exosomes1
Top 5 TargetCount
PSMA(Prostate-specific membrane antigen)3
ALDOA(aldolase, fructose-bisphosphate A)1
PDL1(Programmed death-ligand 1)1
HER2(Receptor tyrosine-protein kinase erbB-2)1
RRM2(ribonucleotide reductase regulatory subunit M2)1

Related

10
Drugs associated with Beijing Tumor Hospital
EVM-16
Target-
Mechanism
Immunostimulants
Active Org.
Beijing Tumor HospitalBeijing Tumor Hospital [+1]
Originator Org.
Everest Medicines Ltd.Everest Medicines Ltd.
Active Indication
Relapsed Solid Neoplasm [+1]
Inactive Indication-
Drug Highest PhasePhase 1
First Approval Ctry. / Loc.-
First Approval Date-
[68Ga]Ga-P137
Target
PSMA
Mechanism
PSMA inhibitors
Active Org.
Beijing Tumor HospitalBeijing Tumor Hospital [+1]
Originator Org.
Peking University First Hospital
Active Indication
Prostatic Cancer
Inactive Indication-
Drug Highest PhaseClinical
First Approval Ctry. / Loc.-
First Approval Date-
⁶⁸Ga-NOTA-MAL-MZHER2:342
Target
HER2
Mechanism
HER2 stimulants
Active Org.
Beijing Tumor HospitalBeijing Tumor Hospital
Originator Org.-
Active Indication
Adenocarcinoma of Lung [+1]
Inactive Indication-
Drug Highest PhaseClinical
First Approval Ctry. / Loc.-
First Approval Date-
159
Clinical Trials associated with Beijing Tumor Hospital
ChiCTR2600116769
/ Not yet recruitingPhase 4IIT
A Prospective, Single-Arm, Phase II Clinical Study of Nimotuzumab Combined with Tislelizumab as Neoadjuvant Therapy for Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma Who Are Intolerant to Platinum-Based Chemotherapy
NCT07357532
/ Not yet recruitingPhase 2IIT
Exploration of Treatment Strategies After Concurrent Chemoradiotherapy for Limited-stage Small Cell Lung Cancer (LS-SCLC) Guided by Molecular Residual Disease (MRD)
ChiCTR2500114409
/ Not yet recruitingNot ApplicableIIT
The omission of axillary dissection after neoadjuvant chemotherapy in node-positive breast cancer patients
100 Clinical Results associated with Beijing Tumor Hospital
Login to view more data
0 Patents (Medical) associated with Beijing Tumor Hospital
Login to view more data
100 Deals associated with Beijing Tumor Hospital
Login to view more data
100 Translational Medicine associated with Beijing Tumor Hospital
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 06 Feb 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
7
1
Phase 1
Other
3
Login to view more data

Current Projects

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free